Glenmede Trust’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-4,440
Closed -$352K 1258
2020
Q4
$352K Sell
4,440
-2,004
-31% -$145K ﹤0.01% 929
2020
Q3
$399K Buy
6,444
+968
+18% +$63K ﹤0.01% 851
2020
Q2
$361K Buy
5,476
+2,952
+117% +$177K ﹤0.01% 852
2020
Q1
$138K Hold
2,524
﹤0.01% 1313
2019
Q4
$138K Buy
2,524
+424
+20% +$22.2K ﹤0.01% 1313
2019
Q3
$102K Buy
2,100
+80
+4% +$4.01K ﹤0.01% 1399
2019
Q2
$105K Buy
2,020
+100
+5% +$5.04K ﹤0.01% 1380
2019
Q1
$95K Buy
1,920
+1,120
+140% +$50.4K ﹤0.01% 1433
2018
Q4
$28K Sell
800
-3,532
-82% -$148K ﹤0.01% 1843
2018
Q3
$221K Sell
4,332
-5,728
-57% -$254K ﹤0.01% 1109
2018
Q2
$372K Hold
10,060
﹤0.01% 892
2018
Q1
$324K Hold
10,060
﹤0.01% 1037
2017
Q4
$324K Hold
10,060
﹤0.01% 1037
2017
Q3
$303K Buy
10,060
+376
+4% +$11.2K ﹤0.01% 1080
2017
Q2
$245K Hold
9,684
﹤0.01% 1141
2017
Q1
$245K Buy
9,684
+1,996
+26% +$51.5K ﹤0.01% 1141
2016
Q4
$197K Hold
7,688
﹤0.01% 1209
2016
Q3
$209K Sell
7,688
-212
-3% -$5.82K ﹤0.01% 1177
2016
Q2
$222K Buy
7,900
+212
+3% +$5.45K ﹤0.01% 1152
2016
Q1
$181K Hold
7,688
﹤0.01% 1187
2015
Q4
$172K Hold
7,688
﹤0.01% 1214
2015
Q3
$177K Hold
7,688
﹤0.01% 1206
2015
Q2
$188K Hold
7,688
﹤0.01% 1240
2015
Q1
$192K Hold
7,688
﹤0.01% 1264
2014
Q4
$177K Buy
7,688
+1,384
+22% +$31.7K ﹤0.01% 1350
2014
Q3
$147K Sell
6,304
-200
-3% -$4.69K ﹤0.01% 1297
2014
Q2
$150K Hold
6,504
﹤0.01% 1271
2014
Q1
$138K Hold
6,504
﹤0.01% 1307
2013
Q4
$153K Sell
6,504
-300
-4% -$6.5K ﹤0.01% 1250
2013
Q3
$136K Hold
6,804
﹤0.01% 1273
2013
Q2
$117K Buy
+6,804
New +$113K ﹤0.01% 1259

Other funds holding TECH

Glenmede Trust's TECH Position: Q1 2021 in Review

Glenmede Trust sold out of Bio-Techne (TECH) in Q1 2021, closing a stake of 4,440 shares — an estimated $352K sold.

Glenmede Trust first reported a position in TECH in Q2 2013 and held it in 31 quarters. The position peaked at $399K in Q3 2020. 471 funds tracked by Wall St. Rank hold TECH as of Q1 2021.

  • Glenmede Trust reported no remaining Bio-Techne position as of Q1 2021 after selling out during the quarter.
  • Glenmede Trust sold 4,440 Bio-Techne shares in Q1 2021, an estimated $352K.
  • Glenmede Trust first reported a position in Bio-Techne in Q2 2013 and held it in 31 quarters.
  • Glenmede Trust's Bio-Techne position peaked at $399K in Q3 2020.
  • 471 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2021.

Based on Glenmede Trust's 13F filing for Q1 2021, filed 18 May 2021.